Matteo Mori

Matteo Mori

Università degli Studi di Milano - Milano / Italy
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5043017
University of Milan
person_outline Matteo Mori's MOST POPULAR ARTICLES
1-) Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents LR Chiarelli, M Mori, D Barlocco, G Beretta, A Gelain, E Pini, M Porcino, ... European journal of medicinal chemistry 155, 754-763, 2018 602018
2-) Signal transducer and activator of transcription protein 3 (STAT3): an update on its direct inhibitors as promising anticancer agentsA Gelain, M Mori, F Meneghetti, S VillaCurrent Medicinal Chemistry 26 (27), 5165-5206, 2019392019
3-) New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular …E Pini, G Poli, T Tuccinardi, LR Chiarelli, M Mori, A Gelain, L Costantino, ...Molecules 23 (7), 1506, 2018392018
4-) New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agentsLR Chiarelli, M Mori, G Beretta, A Gelain, E Pini, JC Sammartino, ...Journal of Enzyme Inhibition and Medicinal Chemistry 34 (1), 823-828, 2019332019
5-) An overview on the potential antimycobacterial agents targeting serine/threonine protein kinases from Mycobacterium tuberculosisM Mori, JC Sammartino, L Costantino, A Gelain, F Meneghetti, S Villa, ...Current Topics in Medicinal Chemistry 19 (9), 646-661, 2019292019